Outlook Therapeutics, Inc.
OTLK
Revenue
1.51M
▼-4.35M▼-74.28%
69 Months ChangeAssets
18.24M
▼-345.61k▼-1.86%
3 Months ChangeLiabilities
56.79M
▲6.02M▲11.85%
3 Months ChangeFree Cash Flow
-10.02M
▼-271.59k▼-2.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001104659-26-024189
2026-02-18
Form 8-K
ID: 0001104659-26-017118
2026-02-17
Form 10-Q
ID: 0001104659-26-016554
2026-02-17
Form 8-K
ID: 0001104659-26-015887
2026-02-11
Form 8-K
ID: 0001104659-26-013470
2026-01-02
Form 8-K
ID: 0001104659-26-000066
2025-12-19
Form 8-K
ID: 0001104659-25-122786
2025-11-13
Form 8-K
ID: 0001104659-25-111316
2025-11-03
Form 8-K
ID: 0001104659-25-105633
2025-09-29
Form 8-K
ID: 0001104659-25-094558